Search results for

As Iraq continues to grapple with the difficult task of rebuilding amid a declining security situation, a reconstruction of a different kind has taken place in the IP field. Stéphanie Bodoni explores the struggle to provide patent and trade mark protection

Pharmaceutical patents are at the forefront of litigation in Canada. Andrew Bernstein and Grant Worden of Torys LLP in Toronto explain why, and consider proposed changes to rules on generic drugs

The US Supreme Court this years handed down rulings in two of the most anticipated IP cases of recent years. Sam Mamudi analyzes what the judgments mean for rights owners

The United Arab Emirates recently signed a Trade and Investment Framework Agreement with the United States. The purpose of the agreement is to develop ways for both countries to expand their bilateral trade and investment relationship. The value of trade between the US and the UAE was reported to be in the vicinity of $4.6 billion in the year 2003 and with an open market and a large economy, the Free Trade Agreement (FTA) should bring more investment into the country and this figure could grow exponentially. A good example of how much open markets can do is the success that the various free zones established in the UAE have had. The FTA will also enhance the technology base here. But what does this mean for companies coming into the UAE?

On June 21 2005, the Secretary of Health issued Administrative Order Number 2005-0016, entitled General Policies and Guidelines Governing Brand Names of Products for Registration with the Bureau of Food and Drugs (BFAD). BFAD officials are thought to believe that IP issues relating to brand names have impeded their ability to implement effectively the misbranding provisions of Republic Act 3720, known as the Food, Drugs and Devices and Cosmetics Act. The most important features of the new Order are:

Ben Moshinsky, London

Emma Barraclough, Hong Kong

Enquiries into alleged corruption in Hong Kong have cast light on the hidden role of IP investigators in the fight against counterfeiting. Emma Barraclough reports

Sam Mamudi, New York

On July 13 2005, the English Court of Appeal handed down its judgment in the British Horseracing Board (BHB) v William Hill case. The decision ended a dispute that started in the High Court about five years ago and has involved two trips to the Court of Appeal and one to the European Court of Justice (ECJ).